Goeltz II Robert C. bought RCUS
January 23, 2026 · Form 4 insider transaction
Goeltz II Robert C. bought 24,000 shares of Arcus Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,000
Price
$0.00
Total value
N/A
InsiderGoeltz II Robert C.
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 23, 2026
Filing dateJanuary 26, 2026
Shares owned after91,924
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company.; Includes the unvested portion of the Reporting Person's RSU grants.